Legal notices

Past performance is not a reliable indicator of future results.

This is a non-binding marketing communication. It is provided for information purposes only and does not constitute a public offer, a recommendation, advice or a solicitation to buy or sell fund units, nor is it to be regarded as a solicitation to make an offer to enter into a contract for an investment service or ancillary service.

This is not a recommendation to buy or sell. The information and assessments contained herein do not constitute investment advice or any other recommendation. They are no substitute for individual investment advice. No assurance can be given that the investment objectives will be achieved. Past performance is no guarantee and no indicator of future performance. Please read the prospectus and the Key Information Document (KID) before making a final investment decision. The binding basis for the purchase of the fund is the Key Information Document (KID), the currently valid prospectus together with the management regulations or articles of association, the most recently published and audited annual report and the most recently published unaudited half-yearly report, which are available free of charge in German from the management company Hauck & Aufhäuser Fund Services S.A., 1c, rue Gabriel Lippmann, 5365 Munsbach, Luxembourg and at https://medicalstrategy.de/fonds/medical-bio-health. You can also obtain further information by calling +49-821-259351-14 or by emailing relations@medicalstrategy.de.

Further detailed information on the opportunities and risks is contained in the prospectus and the key investor information document.

Risk class 5 is based on the assumption that the recommended holding period is adhered to. The risk indicator can have a value between 1 and 7. The actively managed fund portfolio is not managed in relation to a benchmark index.

Tax treatment depends on the personal circumstances of the respective investors and may be subject to future changes.

The funds of Medical Strategy GmbH were established under German law and are authorised for distribution in Germany, Austria, the Netherlands and Spain. The units of this fund are not intended for distribution in the USA or to US citizens.

The management company may decide to withdraw the arrangements it has made for the distribution of the units of its undertakings for collective investment in accordance with Article 93a of Directive 2009/65/EC. Information on investor rights is available at https://www.hal-privatbank.com/.

The opinions expressed in this product information reflect the current, carefully prepared assessment of Medical Strategy GmbH; these may change at any time without prior notice. Medical Strategy GmbH and third parties from whom Medical Strategy GmbH obtains information accept no liability for the correctness, completeness, timeliness, accuracy or availability of the data made available and displayed as part of this information service, despite careful procurement and provision. Medical Strategy GmbH and anevis solutions GmbH, which technically produces the presentation/monthly reports, have not verified the data themselves and accept no liability for losses caused by the use of this information or arising in connection with the use of this information.

Use of this information is at your own risk.

Any unauthorised use of this document, in particular its reproduction, processing, forwarding or publication, is prohibited. The author of this document, as well as its affiliated companies, expressly exclude all liability for the accuracy, completeness or timeliness of the information contained herein and the opinions expressed. Any past performance figures, back-test data or historical or forward-looking simulations contained in this document are no guarantee of future developments. An investment refers to the acquisition of units in the fund and not directly to the underlying assets.

Date: 13 January 2026